Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 20 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variantButler, L.; Centenera, M.; Neufing, P.; Buchanan, G.; Choong, C.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M.; Tilley, W.
2004Androgen receptor signaling: mechanism of interleukin-6 inhibitionJia, L.; Choong, C.; Ricciardelli, C.; Kim, J.; Tilley, W.; Coetzee, G.
2017Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancerPonnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.
2017Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancerPaltoglou, S.; Das, R.; Townley, S.; Hickey, T.; Tarulli, G.; Coutinho, I.; Fernandes, R.; Hanson, A.; Denis, I.; Carroll, J.; Dehm, S.; Raj, G.; Plymate, S.; Tilley, W.; Selth, L.
2018Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-bSnell, C.; Gough, M.; Liu, C.; Middleton, K.; Pyke, C.; Shannon, C.; Woodward, N.; Hickey, T.; Armes, J.; Tilley, W.
2013Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progressionButler, M.; Ricciardelli, C.; Tilley, W.; Hickey, T.
2013Ski-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcriptionAbankwa, D.; Millard, S.; Martel, N.; Choong, C.; Yang, M.; Butler, L.; Buchanan, G.; Tilley, W.; Ueki, N.; Hayman, M.; Leong, G.
2015Targeting chromatin binding regulation of constitutively active AR variants to overcome prostate cancer resistance to endocrine-based therapiesChan, S.; Selth, L.; Li, Y.; Nyquist, M.; Miao, L.; Bradner, J.; Raj, G.; Tilley, W.; Dehm, S.
2013Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancerRavindranathan, P.; Lee, T.; Yang, L.; Centenera, M.; Butler, L.; Tilley, W.; Hsieh, J.; Ahn, J.; Raj, G.
2003Dynamic methylation of histone H3 at lysine 4 in transcriptional regulation by the androgen receptorKim, J.; Jia, L.; Tilley, W.; Coetzee, G.